- abnormal vertebrae morphology / IMPC
- abnormal rib morphology / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased hematocrit / IMPC
- decreased leukocyte cell number / IMPC
- increased granulocyte number / IMPC
- abnormal coat/ hair morphology / IMPC
- abnormal cranium morphology / IMPC
- abnormal hindlimb morphology / IMPC
- abnormal autopod morphology / IMPC
- kinked tail / IMPC
- short tail / IMPC
- tremors / IMPC
- abnormal body length / IMPC
- decreased body length / IMPC
- decreased body weight / IMPC
- hyperactivity / IMPC
- decreased locomotor activity / IMPC
- abnormal gait / IMPC
- abnormal response to new environment / IMPC
- abnormal startle reflex / IMPC
- trunk curl / IMPC
- abnormal vocalization / IMPC
- decreased caudal vertebrae number / IMPC
- increased circulating phosphate level / IMPC
- abnormal urination / IMPC
- increased thermal nociceptive threshold / IMPC
- abnormal coat/hair pigmentation / IMPC
- abnormal tail morphology / IMPC
- decreased IgE level / IMPC
- increased mean corpuscular volume / IMPC
- decreased circulating triglyceride level / IMPC
- decreased hemoglobin content / IMPC
- decreased erythrocyte cell number / IMPC
- abnormal bone mineralization / IMPC
- increased circulating alanine transaminase level / IMPC
- increased lactate dehydrogenase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased circulating chloride level / IMPC
- curly tail / IMPC
- increased lean body mass / IMPC
- decreased lean body mass / IMPC
- abnormal pelvic girdle bone morphology / IMPC
- abnormal vertebral arch morphology / IMPC
- vertebral fusion / IMPC
- decreased sacral vertebrae number / IMPC
- abnormal behavior / IMPC
- increased T cell number / IMPC
- decreased B cell number / IMPC
- abnormal retina pigmentation / IMPC
- decreased circulating cholesterol level / IMPC
- narrow eye opening / IMPC
- decreased circulating serum albumin level / IMPC
- thrombocytosis / IMPC
- increased hemoglobin content / IMPC
- decreased circulating total protein level / IMPC
- increased mean corpuscular hemoglobin concentration / IMPC
- increased CD4-positive, alpha-beta T cell number / IMPC
- decreased mature B cell number / IMPC
- increased IgG2b level / IMPC
- increased IgG3 level / IMPC
- decreased circulating amylase level / IMPC
- increased total body fat amount / IMPC
- increased bone mineral content / IMPC
- preweaning lethality, incomplete penetrance / IMPC
B6Dnk;B6Brd;B6N-Tyrc-Brd Mysm1tm1a(KOMP)Wtsi/Wtsi
Status | Available to order |
EMMA ID | EM:12102 |
International strain name | B6Dnk;B6Brd;B6N-Tyrc-Brd Mysm1tm1a(KOMP)Wtsi/Wtsi |
Alternative name | EPD0019_1_A05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Mysm1tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Mysm1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0019_1_A05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Wellcome Trust Sanger Institute, Hinxton, United Kingdom |
Animals used for archiving | heterozygous C57BL/6Dnk;C57BL/6N |
Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome / Orphanet_508542
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased total body fat amount / IMPC
- abnormal rib morphology / IMPC
- abnormal behavior / IMPC
- decreased leukocyte cell number / IMPC
- decreased locomotor activity / IMPC
- increased lactate dehydrogenase level / IMPC
- abnormal tail morphology / IMPC
- increased circulating phosphate level / IMPC
- decreased lean body mass / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal hindlimb morphology / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal vertebrae morphology / IMPC
- decreased body weight / IMPC
- decreased circulating triglyceride level / IMPC
- abnormal urination / IMPC
- decreased erythrocyte cell number / IMPC
- decreased hematocrit / IMPC
- increased hemoglobin content / IMPC
- abnormal gait / IMPC
- abnormal coat/ hair morphology / IMPC
- hyperactivity / IMPC
- abnormal response to new environment / IMPC
- increased mean corpuscular hemoglobin concentration / IMPC
- decreased body length / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- increased lean body mass / IMPC
- abnormal body length / IMPC
- decreased IgE level / IMPC
- kinked tail / IMPC
- decreased sacral vertebrae number / IMPC
- increased mean corpuscular volume / IMPC
- decreased B cell number / IMPC
- decreased circulating serum albumin level / IMPC
- abnormal pelvic girdle bone morphology / IMPC
- increased circulating chloride level / IMPC
- decreased caudal vertebrae number / IMPC
- decreased hemoglobin content / IMPC
- thrombocytosis / IMPC
- abnormal cranium morphology / IMPC
- abnormal startle reflex / IMPC
- abnormal coat/hair pigmentation / IMPC
- increased bone mineral content / IMPC
- tremors / IMPC
- increased CD4-positive, alpha-beta T cell number / IMPC
- curly tail / IMPC
- abnormal vertebral arch morphology / IMPC
- short tail / IMPC
- abnormal bone mineralization / IMPC
- abnormal autopod morphology / IMPC
- vertebral fusion / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating total protein level / IMPC
- abnormal retina pigmentation / IMPC
- increased T cell number / IMPC
- increased granulocyte number / IMPC
- increased circulating alanine transaminase level / IMPC
- narrow eye opening / IMPC
- decreased mature B cell number / IMPC
- increased thermal nociceptive threshold / IMPC
- decreased circulating amylase level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- trunk curl / IMPC
- increased IgG2b level / IMPC
- increased IgG3 level / IMPC
- abnormal vocalization / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).